AeroVironment secured a $405 million international order for its LOCUST X3 high-energy laser weapon systems, enhancing counter-drone defense capabilities in the Middle East amid rising regional security threats. Following the announcement, AeroVironment's shares rose 2% to $125.41. The order reflects growing demand for advanced defense technology in volatile regions and supports AeroVironment's market position, with analysts maintaining an Outperform rating on the stock.
AeroVironment's $405 million laser weapon systems order provides context for today's Industrials sector performance on Pluang. For readers following Industrials, here is Pluang's market snapshot as of Nov 12, 2026 04:22 WIB: out of 135 priced US Industrials stocks, 105 rose and 29 fell. Notable movers include Powell Industries (POWL) at USD 146.07 with a 5.69% increase and a typical hold time of 17 days, Rocket Lab USA Inc (RKLB) at USD 66.27 up 5.68% with 96% sell order activity, and Comfort Systems USA Inc (FIX) at USD 1,163.38 up 5.19% with 100% sell order activity and a typical hold time of 43 days.
Vestas Wind Systems reported Q3 2026 earnings per share of $0.13 and revenue of $6.34 billion, both below analyst expectations. The company's profit was impacted by weak sales volume and a broken turbine blade. Following the earnings miss, Vestas' sh...
The global beverage market is projected to grow from $2.03 trillion in 2026 to $2.78 trillion by 2032, at a CAGR of 5.35%. Growth is fueled by rising demand for nonalcoholic and functional beverages, convenience packaging, and premium products for sp...
DelveInsight's 2026 report reveals more than 200 GLP-1 receptor agonists and incretin-based therapies are in development by over 180 companies, targeting conditions like type 2 diabetes, obesity, and related metabolic disorders. Key players such as E...
Tennessee American Water has applied an additional $13.07 credit to customer accounts, bringing total PFAS settlement refunds to over $84 per customer. This credit follows approval from the Tennessee Public Utility Commission, allowing the company to...
PepGen Inc. stock surged over 100% following positive Phase 2 top-line results for its DM1 treatment PGN-EDODM1, which showed a 46.5% mean splicing correction and functional improvements with good safety at 10 mg/kg over four doses. Despite these pro...
